Rapid infectious disease test Xpert®

for genesMRSAclinical

Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are a major cause of morbidity and mortality worldwide1 People with methicillin-resistant Staphylococcus aureus (MRSA) infections are 64 % more likely to die than people with drug-sensitive infections2 Active surveillance of inpatients for MRSA is a strategy for preventing health care-acquired infections (HAIs) by MRSA1 The Solution Xpert® MRSA NxG is a qualitative in-vitro diagnostic test intended for the detection of methicillin-resistant S. aureus (MRSA) DNA directly from nasal swabs in patients at risk for nasal colonization* Quickly identify MRSA-colonized patients who may require contact precautions to aid with transmission risks and outbreak management The Impact Rapid implementation of infection control measures and patient bed management1 Strong clinical performance compared to other commercial tests1 Minutes of hands-on time with results in 70 minutes on a random-access platform1